To date, two-thirds of Japanese adenocarcinomas and a little more than half of Caucasian adenocarcinomas have mutually exclusive oncogenic mutations or other genetic alterations including EGFR, KRAS, MET, ALK and HER2 (27). This evidence concerns the gene ALK and adenocarcinoma.